Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients

Cancer Genomics and Proteomics

Saved in:

Bibliographic Details
Main Authors:	Wong, A.L.-A., Yap, H.-L., Yeo, W.-L., Soong, R., Ng, S.-S., Wang, L.-Z., Cordero, M.T., Yong, W.-P., Goh, B.-C., Lee, S.-C.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Subjects:	Breast cancer Carboplatin Gemcitabine Genetic polymorphisms Pharmacogenetics
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110740
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014)

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014)

Pharmacogenetics of Doxorubicin in Asian Breast Cancer Patients
by: SUMAN LAL CHIRAMMAL SUGUNAN
Published: (2011)

PHARMACODYNAMICS, PHARMACOKINETICS AND PHARMACOGENETICS OF DOXORUBICIN IN SINGAPOREAN BREAST CANCER PATIENTS
by: FAN LU
Published: (2011)

Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients
by: Soo, R.A., et al.
Published: (2011)

Does saturable formation of gemcitabine triphosphate occur in patients?
by: Tham, L.-S., et al.
Published: (2014)

Pharmacogenetics of Tamoxifen in Asian Breast Cancer Patients
by: LIM SIOK LIU
Published: (2013)

Systemic therapies for pancreatic cancer - the role of pharmacogenetics
by: Soo, R.A., et al.
Published: (2014)

Recent progress and clinical importance on pharmacogenetics in cancer therapy
by: Soh, T.I.P., et al.
Published: (2014)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, Vachiranee, et al.
Published: (2018)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2011)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2014)

Pharmacogenetics of Warfarin Should we test?
by: Pantep Angchaisuksiri, et al.
Published: (2022)

8q24 and 17q Prostate cancer susceptibility loci in a multiethnic Asian cohort
by: Chan, J.Y., et al.
Published: (2014)

DNA chip platform: a high-throughput genotyping technology for genetic diagnosis and pharmacogenetic profiling
by: LU YI
Published: (2010)

Pharmacogenetics approach to therapeutics
by: Koo, S.H., et al.
Published: (2011)

Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effect
by: Wang, L.-Z., et al.
Published: (2014)

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
by: Lee, JW, et al.
Published: (2022)

Pharmacology of Gemcitabine in the Asian Population
by: WANG LINGZHI
Published: (2010)

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies
by: Loh, M., et al.
Published: (2014)

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer
by: Wong, N.-S., et al.
Published: (2014)

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
by: Iwanski, G.B., et al.
Published: (2015)

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
by: Ma, B., et al.
Published: (2011)

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
by: Ma, B., et al.
Published: (2014)

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group study
by: Soo, R.A., et al.
Published: (2014)

The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing
by: Chan, S.L., et al.
Published: (2014)

An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography
by: Wang, L.-Z., et al.
Published: (2014)

An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography
by: Wang, L.-Z., et al.
Published: (2012)

Teaching of clinical pharmacogenetics for pharmacy students at the National University of Singapore
by: Zhou, S.F.
Published: (2014)

SYSTEMS LEVEL ANALYSIS OF CELLULAR RESPONSES TO GEMCITABINE IN B-CELL LYMPHOMA
by: CHAN KAIXUAN JUSTIN
Published: (2022)

Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public
by: Chan, S.L., et al.
Published: (2014)

Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
by: Chaudhury, A., et al.
Published: (2014)

Pharmacokinetics and pharmacogenetics of mycophenolic acid in Asian renal transplant patients in Singapore
by: YAU WAI PING
Published: (2011)

Illness perceptions of Indonesian women with breast cancer
by: Wenny Savitri
Published: (2010)

The role of VEGF polymorphisms in Thai breast cancer patients
by: Doonyapat Sa-nguanraksa
Published: (2023)

Clinical pharmacogenetics and potential application in personalized medicine
by: Zhou, S.-F., et al.
Published: (2014)

PHARMACOGENETICS OF MONOCARBOXYLATE TRANSPORTERS
by: LEAN CHOO BEE
Published: (2012)

FOLATE RECEPTOR TARGETED LIPOSOMES AS THE ENABLING TECHNOLOGY FOR THE DELIVERY OF CHEMOTHERAPEUTICS IN THE TREATMENT OF OVARIAN CANCER
by: ANUMITA CHAUDHURY
Published: (2012)

From discovery to treatment: Stressors, coping, and reflections of female breast cancer survivors
by: Rufino, Junn, et al.
Published: (2004)

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway
by: Woo, C.C., et al.
Published: (2014)